Noninvasive Assessment of Nonalcoholic Fatty Liver Disease in Obese or Overweight Patients Sven M.A. Francque, An Verrijken, Ilse Mertens, Guy Hubens,

Slides:

Advertisements

Similar presentations

Esophageal Adenocarcinoma

Advertisements

The Role of Psychosocial Care in Adapting to Health Care Reform

Abnormal Liver Tests and Fatty Liver on Ultrasound

Thrombocytopenia With Abnormal Liver Function Tests

Ashwin N. Ananthakrishnan, Millie D. Long, Christopher F

Long-Term Follow-Up of Patients With Nonalcoholic Fatty Liver

Flavia D. Mendes, Ayako Suzuki, Schuyler O. Sanderson, Keith D

Incorrect Calculation and Inappropriate Interpretation: Accuracy of International Guidelines for Identifying Significant Fibrosis in e Antigen–Negative.

Ruben Hernaez, MD, MPH, PhD Clinical Gastroenterology and Hepatology

Mauricio Garcia-Saenz-de-Sicilia, MD, Andres Duarte-Rojo, MD, MS, DSC

Gauree Gupta, Ebbing Lautenbach, James D. Lewis

Management of Dyslipidemia as a Cardiovascular Risk Factor in Individuals With Nonalcoholic Fatty Liver Disease Kathleen E. Corey, Naga Chalasani Clinical.

Volume 145, Issue 4, Pages e4 (October 2013)

Todd H. Baron, MD, Thomas C. Smyrk, MD

New Model for End Stage Liver Disease Improves Prognostic Capability After Transjugular Intrahepatic Portosystemic Shunt Jennifer Guy, Ma Somsouk, Stephen.

Right Upper Quadrant Pain and a Normal Abdominal Ultrasound

The Long Winding Road to Transplant: How Sarcopenia and Debility Impact Morbidity and Mortality on the Waitlist Rahima A. Bhanji, Elizabeth J. Carey,

Volume 149, Issue 2, Pages (August 2015)

Prevalence and Mechanisms of Malnutrition in Patients With Advanced Liver Disease, and Nutrition Management Strategies Kally Cheung, Samuel S. Lee, Maitreyi.

Retinol-Binding Protein 4: A Promising Circulating Marker of Liver Damage in Pediatric Nonalcoholic Fatty Liver Disease Valerio Nobili, Naim Alkhouri,

Stephen A. Harrison, MD, FACP Clinical Gastroenterology and Hepatology

Amnon Sonnenberg, MD, MSc, Brent Y. Lee, MD

Andree Koop, Michael J. Bartel, Dawn Francis

Issue Highlights Clinical Gastroenterology and Hepatology

Long-Term Outcomes of Nonalcoholic Fatty Liver Disease: From Nonalcoholic Steatohepatitis to Nonalcoholic Steatofibrosis Zobair M. Younossi Clinical.

Abstracts from Around the World

Volume 149, Issue 2, Pages (August 2015)

Cytokeratin 18 Fragment Levels as a Noninvasive Biomarker for Nonalcoholic Steatohepatitis in Bariatric Surgery Patients Dima L. Diab, Lisa Yerian, Philip.

Issue Highlights Clinical Gastroenterology and Hepatology

Michael Charlton Clinical Gastroenterology and Hepatology

Incidence of Bleeding Following Invasive Procedures in Patients With Thrombocytopenia and Advanced Liver Disease Edoardo G. Giannini, Alfredo Greco,

An Association Between Microscopic Colitis and Celiac Disease

Prevalence and Challenges of Liver Diseases in Patients With Chronic Hepatitis C Virus Infection Ira M. Jacobson, Gary L. Davis, Hashem El–Serag, Francesco.

Obstructive Jaundice Caused by Intraductal Hepatocellular Carcinoma

Efficacy and Durability of Radiofrequency Ablation for Barrett's Esophagus: Systematic Review and Meta-analysis Eric S. Orman, Nan Li, Nicholas J. Shaheen

Chan Wah Kheong, Nik Raihan Nik Mustapha, Sanjiv Mahadeva

Abnormal Liver Tests and Fatty Liver on Ultrasound

William D. Leslie Clinical Gastroenterology and Hepatology

New Models of Gastroenterology Practice

Rajasekhara R. Mummadi, Krishna S

Endoscopic Ultrasound–Guided Cholecystoduodenostomy for Acute Cholecystitis in a Patient With Thrombocytopenia and End-Stage Liver Disease Awaiting Transplantation

Issue Highlights Clinical Gastroenterology and Hepatology

Dushyant Singh, Reetu Singh, Wendell K. Clarkston

Histologic Changes in Liver Tissue From Patients With Chronic Hepatitis B and Minimal Increases in Levels of Alanine Aminotransferase: A Meta-analysis.

Amnon Sonnenberg Clinical Gastroenterology and Hepatology

Peter Bytzer Clinical Gastroenterology and Hepatology

Colorectal Cancer Screening: How to Stop a Moving Target

Refining Sample-Size Estimations Based Upon Placebo Response in Trials of Agents for Nonalcoholic Fatty Liver Disease Veeral Ajmera, MD, MAS, Rohit Loomba,

Issue Highlights Clinical Gastroenterology and Hepatology

Effects of Different Coping Strategies on Physical and Mental Health of Patients With Irritable Bowel Syndrome Lilian Dindo, PhD Clinical Gastroenterology.

Issue Highlights Clinical Gastroenterology and Hepatology

Heiko Pohl, Douglas J. Robertson

Complete Resolution of Nonalcoholic Fatty Liver Disease After Bariatric Surgery: A Systematic Review and Meta-analysis Yung Lee, Aristithes G. Doumouras,

Elizabeth Mileti, Philip Rosenthal, Marion G. Peters

Suna Yapali, MD, Anna S. Lok, MD, FRCP

John S. Kane, Olorunda Rotimi, Simon M

Relationship Between Changes in Serum Levels of Keratin 18 and Changes in Liver Histology in Children and Adults With Nonalcoholic Fatty Liver Disease

Thrombocytopenia With Abnormal Liver Function Tests

Issue Highlights Clinical Gastroenterology and Hepatology

Volume 142, Issue 6, Pages e4 (May 2012)

Hepatitis C Virus Infection, Age, and Hispanic Ethnicity Increase Mortality From Liver Cancer in the United States Zobair M. Younossi, Maria Stepanova

A 27-Year-Old Woman With Constipation: Diagnosis and Treatment

Christopher Hung, Desmond Leddin

A 42–Year–Old Woman With a New Diagnosis of Sclerosing Cholangitis

Coagulation in Liver Disease: A Guide for the Clinician

Issue Highlights Clinical Gastroenterology and Hepatology

Lauren B. Gerson, Peter J. Kahrilas, Ronnie Fass

Medical Therapy for Refractory Pediatric Crohn’s Disease

The Role of Psychosocial Care in Adapting to Health Care Reform

Volume 135, Issue 6, Pages (December 2008)

Presentation transcript:

Noninvasive Assessment of Nonalcoholic Fatty Liver Disease in Obese or Overweight Patients Sven M.A. Francque, An Verrijken, Ilse Mertens, Guy Hubens, Eric Van Marck, Paul Pelckmans, Peter Michielsen, Luc Van Gaal Clinical Gastroenterology and Hepatology Volume 10, Issue 10, Pages 1162-1168 (October 2012) DOI: 10.1016/j.cgh.2012.06.019 Copyright © 2012 AGA Institute Terms and Conditions

Figure 1 Histologic lesions. Pie plot of the distribution of patients according to the grade of steatosis (A), NAS (B), and fibrosis stage (C). Clinical Gastroenterology and Hepatology 2012 10, 1162-1168DOI: (10.1016/j.cgh.2012.06.019) Copyright © 2012 AGA Institute Terms and Conditions

Figure 2 Comparison of scoring systems. ROC of the different scoring systems for the diagnosis of NASH defined according to Brunt et al18 (A), for the diagnosis of NASH defined according to Kleiner et al17 (B), for the diagnosis of significant fibrosis (C), and for the diagnosis of advanced fibrosis (D) in the design cohort. Clinical Gastroenterology and Hepatology 2012 10, 1162-1168DOI: (10.1016/j.cgh.2012.06.019) Copyright © 2012 AGA Institute Terms and Conditions